Treatment with a combination of ibrutinib and rituximab improved progression-free survival (PFS) over rituximab alone in patients with Waldenström macroglobulinemia (WM), according to results… Continue reading
We would like to thank everyone who was able to attend the New Toronto Support Group meeting in April.
And a special thank you to our guest speaker Dr. Christine Chen
Please click the link below for a copy of… Continue reading
On Wednesday, June 27th, 2018 from 1:30PM – 2:30PM EST, Dr. Jorge Castillo of Dana-Farber Cancer Institute and Dr. Morie Gertz of Mayo Clinic will engage in a discussion on “Progress in the Treatment of… Continue reading
Recorded Session from the Lymphoma Research Foundation – 2017 North American Educational Forum on Lymphoma
Until recently, it was not possible for WM patients to be safely vaccinated against varicella zoster, commonly called shingles, because the vaccine, Zostavax, was a live virus vaccine… Continue reading